Table 3.
Parameter description | Parametera | Unit | Value | Precision (%) |
---|---|---|---|---|
PK model | ||||
Apparent oral clearance | TV(CL/F) | Liters/h | 3.42 | |
Apparent vol of distribution | TV(V/F) | Liters | 29.2 | |
Fast absorption rate constant | TV(ka, fast) | Liters/h | 3.56 | |
Slow absorption rate constant | TV(ka, slow) | Liters/h | 1.25 | |
Duration of zero-order absorption | TV(Dur) | h | 0.29 | |
Proportion of fast absorbers | Pfast | 0.556 | ||
Slope effect of covariate | θCL/F,WT | 0.0545 | ||
Slope effect of covariate | θV/F,WT | 0.433 | ||
Difference in V/F between males and females | θV/F,SEX | Liters | 4.55 | |
Change in DUR following a fixed-dose combination | θDur,FDC | h | −0.0904 | |
Stochastic model parameters | BSV(CL/F) | 0.0351 | ||
BSV(V/F) | 0.0251 | |||
BSV(Dur) | 0.957 | |||
IOV(KA) | 0.623 | |||
RES. ADD | mg/liter | 1.89 | ||
RES. PROP | 0.0907 | |||
PD model | ||||
Probability of hepatotoxicity within 2 mo of comedication only | BASE | 0.0452 | 5 | |
AUC at which 50% of the maximum probability (1) is reached | LAUCT50 | 8.4786 | 14 | |
Exponent | EXPN | 3.45 | 7 |
TV, population-estimated typical value; θ, fixed-effect parameter; BSV, between-subject variability; IOV, interoccasion variability; RES. ADD, additive residual error; RES. PROP, proportional residual error.